Off-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union.

Dal-Ré, RafaelCalvo, CristinaNeth, Olaf2023-05-032023-05-032022-06-26http://hdl.handle.net/10668/19910enHumansChild, PreschoolEuropean UnionBNT162 VaccineCOVID-19COVID-19 VaccinesOff-Label UseOff-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union.research article35657672open access10.1111/apa.164421651-2227PMC9347686https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347686https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347686/pdf